Advanced Search
MyIDEAS: Login to follow this author

Christopher Joseph McCabe

Contents:

This is information that was supplied by Christopher McCabe in registering through RePEc. If you are Christopher Joseph McCabe , you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name: Christopher
Middle Name: Joseph
Last Name: McCabe
Suffix:

RePEc Short-ID: pmc184

Email: [This author has chosen not to make the email address public]
Homepage: http://www.leeds.ac.uk/lihs/auhe/People/McCabe_C.html
Postal Address:
Phone:

Affiliation

(70%) University of Alberta, Faculty of Medicine and Dentistry
Homepage: http://www.med.ualberta.ca/
Location: Edmonton, Alberta
(15%) Academic Unit of Health Economics
Leeds Institute of Health Sciences
University of Leeds
Location: Leeds, United Kingdom
Homepage: http://medhealth.leeds.ac.uk/auhe
Email:
Phone: Charles Thackrah Building, 101 Clarendon Road, LEEDS LS9 2LJ
Fax: +44 (0) 113 343 3470
Postal:
Handle: RePEc:edi:heleeuk (more details at EDIRC)
(15%) Department of Economics
University of Alberta
Location: Edmonton, Canada
Homepage: http://www.uofaweb.ualberta.ca/economics/
Email:
Phone: (780) 492-3406
Fax: (780) 492-3300
Postal: 8-14 HM Tory, Edmonton, Alberta, T6G 2H4
Handle: RePEc:edi:deualca (more details at EDIRC)

Works

as in new window

Working papers

  1. Samer A Kharroubi & Richard Edlin & David Meads & Chantelle Browne & Julia Brown & Christopher McCabe, 2013. "Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from Eortic QLQ Data in Myeloma for Use in Cost effectiveness Analysis," Working Papers 1308, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  2. Richard Edlin & Christopher McCabe & David Meads, 2013. "Assignment errors and the valuation of EQ-5D health states-do responses mean what we think they mean?," Working Papers 1304, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  3. Christopher McCabe & Richard Edlin & Peter Hall & Klemens Wallner, 2013. "Leasing health technologies- an affordable and effective reimbursement strategy for innovative technologies?," Working Papers 1302, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  4. Peter S Hall & Christopher McCabe & Richard Edlin & Julia Brown & Claire Hulme & David Cameron, 2013. "Evidence needs for licensing and reimbursement," Working Papers 1301, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  5. Christopher McCabe & Paul Baxter & Roberta Longo & Peter Hall & Jenny Hewison & Mehran Afshar & Geoff Hall, 2013. "Methods for Identifying the Cost-effective Case Definition Cut-off for Sequential Monitoring Tests: an Extension of Phelps and Mushlin," Working Papers 1303, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  6. Christopher McCabe & Richard Edlin & Peter Hall, 2012. "Navigating time and uncertainty in health technology appraisal: would a map help?," Working Papers 1201, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  7. Peter S Hall & Richard Edlin & Samer Kharroubi & Walter Gregory & Christopher McCabe, 2011. "Expected Net Present Value of Sample Information: from burden to investment," Working Papers 1101, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  8. Chantelle Browne & Roberta Longo & Richard Edlin & Jennifer Roberts & Christopher McCabe, 2011. "Challenges in modelling censored health state preference data: Explorations with the EQ-5D and HUI2," Working Papers 1103, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  9. Yemi Oluboyede & Sandy Tubeuf & Chris McCabe, 2011. "Measuring health outcomes of adolescents: report from a pilot study," Working Papers 1102, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  10. Richard Edlin & Roberta Longo & Christopher McCabe, 2010. "Supra-states and censoring in health utility modelling: an examination of their importance in the EQ-5D tariff," Working Papers 1002, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  11. Peter Hall & Claire Hulme & Christopher McCabe & Yemi Oluboyede & Jeff Round & David A Cameron, 2010. "Updated cost-effectiveness analysis of trastuzumab for early breast cancer:A UK perspective considering long-term toxicity and pattern of recurrence," Working Papers 1001, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  12. Richard Edlin & Christopher McCabe & Jeff Round & Judy Wright & Karl Claxton & Mark Sculpher & Richard Cookson, 2010. "Understanding Harris’ understanding of CEA: is cost effective resource allocation undone?," Working Papers 1005, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
  13. McCabe, C & Claxton, K & Culyer, AJ, 2008. "The NICE Cost-Effectiveness Threshold: What it is and What that Means," MPRA Paper 26466, University Library of Munich, Germany.
  14. Karl Claxton & Simon Eggington & Laura Ginnelly & Susan Griffin & Christopher McCabe & Zoe Philips & Paul Tappenden & Alan Wailoo, 2005. "A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence," Working Papers 004cherp, Centre for Health Economics, University of York.
  15. McCabe, C & Brazier, J & Gilks, P & Tsuchiya, A & Roberts, J & O'Hagan, A & Stevens, K, 2004. "Estimating population cardinal health state valuation models from individual ordinal (rank) health state preference data," MPRA Paper 29759, University Library of Munich, Germany.
  16. McCabe, C & Stevens, K & Roberts, J & Brazier, JE, 2003. "Health state values for the HUI 2 descriptive system: results from a UK survey," MPRA Paper 29744, University Library of Munich, Germany.

Articles

  1. Peter Hall & Christopher McCabe, 2013. "What Evidence Is There for the Reimbursement of Personalised Medicine?," PharmacoEconomics, Springer, vol. 31(3), pages 181-183, March.
  2. Christopher McCabe & Richard Edlin & Peter Hall, 2013. "Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?," PharmacoEconomics, Springer, vol. 31(9), pages 731-737, September.
  3. Yemi Oluboyede & Sandy Tubeuf & Chris McCabe, 2013. "Measuring health outcomes of adolescents: report from a pilot study," The European Journal of Health Economics, Springer, vol. 14(1), pages 11-19, February.
  4. Christopher McCabe & Richard Edlin & David Meads & Chantelle Brown & Samer Kharroubi, 2013. "Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities," PharmacoEconomics, Springer, vol. 31(8), pages 635-641, August.
  5. Musal, R. Muzaffer & Soyer, Refik & McCabe, Christopher & Kharroubi, Samer A., 2012. "Estimating the population utility function: A parametric Bayesian approach," European Journal of Operational Research, Elsevier, vol. 218(2), pages 538-547.
  6. Tania Stafinski & Devidas Menon & Donald J. Philippon & Christopher McCabe, 2011. "Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different," PharmacoEconomics, Springer Healthcare | Adis, vol. 29(6), pages 475-495.
  7. Peter S. Hall & Claire Hulme & Christopher McCabe & Yemi Oluboyede & Jeff Round & David A. Cameron, 2011. "Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence," PharmacoEconomics, Springer Healthcare | Adis, vol. 29(5), pages 415-432.
  8. Tania Stafinski & Devidas Menon & Christopher McCabe & Donald J. Philippon, 2011. "To Fund or Not to Fund: Development of a Decision-Making Framework for the Coverage of New Health Technologies," PharmacoEconomics, Springer Healthcare | Adis, vol. 29(9), pages 771-780.
  9. Christopher J. McCabe & Tania Stafinski & Richard Edlin & Devidas Menon, 2010. "Access with Evidence Development Schemes: A Framework for Description and Evaluation," PharmacoEconomics, Springer Healthcare | Adis, vol. 28(2), pages 143-152.
  10. Devidas Menon & Christopher J. McCabe & Tania Stafinski & Richard Edlin, 2010. "Principles of Design of Access with Evidence Development Approaches: A Consensus Statement from the Banff Summit," PharmacoEconomics, Springer Healthcare | Adis, vol. 28(2), pages 109-111.
  11. Tania Stafinski & Christopher J. McCabe & Devidas Menon, 2010. "Funding the Unfundable: Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems," PharmacoEconomics, Springer Healthcare | Adis, vol. 28(2), pages 113-142.
  12. Allan Wailoo & Aki Tsuchiya & Christopher McCabe, 2009. "Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected," PharmacoEconomics, Springer Healthcare | Adis, vol. 27(12), pages 983-989.
  13. Christopher McCabe & Karl Claxton & Anthony J. Culyer, 2008. "The NICE Cost-Effectiveness Threshold: What it is and What that Means," PharmacoEconomics, Springer Healthcare | Adis, vol. 26(9), pages 733-744.
  14. Stevens, Katherine & McCabe, Christopher & Brazier, John & Roberts, Jennifer, 2007. "Multi-attribute utility function or statistical inference models: A comparison of health state valuation models using the HUI2 health state classification system," Journal of Health Economics, Elsevier, vol. 26(5), pages 992-1002, September.
  15. John Brazier & Christopher McCabe, 2007. "Is there a case for using visual analogue scale valuations in CUA' by Parkin and Devlin a response: 'yes there is a case, but what does it add to ordinal data?," Health Economics, John Wiley & Sons, Ltd., vol. 16(6), pages 645-647.
  16. Katherine Stevens & Christopher McCabe & John Brazier, 2007. "Response to Shmueli," Health Economics, John Wiley & Sons, Ltd., vol. 16(7), pages 759-761.
  17. Katherine J. Stevens & Christopher J. McCabe & John E. Brazier, 2006. "Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey," Health Economics, John Wiley & Sons, Ltd., vol. 15(5), pages 527-533.
  18. Mark J. Sculpher & Karl Claxton & Mike Drummond & Chris McCabe, 2006. "Whither trial-based economic evaluation for health care decision making?," Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 677-687.
  19. McCabe, Christopher & Brazier, John & Gilks, Peter & Tsuchiya, Aki & Roberts, Jennifer & O'Hagan, Anthony & Stevens, Katherine, 2006. "Using rank data to estimate health state utility models," Journal of Health Economics, Elsevier, vol. 25(3), pages 418-431, May.
  20. Karl Claxton & Mark Sculpher & Anthony Culyer & Chris McCabe & Andrew Briggs & Ron Akehurst & Martin Buxton & John Brazier, 2006. "Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion," Health Economics, John Wiley & Sons, Ltd., vol. 15(1), pages 1-4.
  21. Christopher McCabe & Katherine Stevens & Jennifer Roberts & John Brazier, 2006. "Erratum to 'Health state values for the health utilities index mark 2 descriptive system: results from a UK valuation survey' Health Economics 2005; 14 (3): 231-244," Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 761-761.
  22. Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan, 2005. "Incorporation of Uncertainty in Health Economic Modelling Studies," PharmacoEconomics, Springer Healthcare | Adis, vol. 23(6), pages 529-536.
  23. Karl Claxton & Mark Sculpher & Chris McCabe & Andrew Briggs & Ron Akehurst & Martin Buxton & John Brazier & Tony O'Hagan, 2005. "Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra," Health Economics, John Wiley & Sons, Ltd., vol. 14(4), pages 339-347.
  24. Katherine Stevens & Christopher McCabe & Carys Jones & Joanne Ashcroft & Sheila Harvey & Kathy Rowan, 2005. "The Incremental Cost Effectiveness of Withdrawing Pulmonary Artery Catheters from Routine Use in Critical Care," Applied Health Economics and Health Policy, Springer Healthcare | Adis, vol. 4(4), pages 257-264.
  25. John Brazier & Ron Akehurst & Alan Brennan & Paul Dolan & Karl Claxton & Chris McCabe & Mark Sculpher & Aki Tsuchyia, 2005. "Should Patients Have a Greater Role in Valuing Health States?," Applied Health Economics and Health Policy, Springer Healthcare | Adis, vol. 4(4), pages 201-208.
  26. Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan, 2005. "The Authors' Reply," PharmacoEconomics, Springer Healthcare | Adis, vol. 23(8), pages 853.
  27. Christopher McCabe & Katherine Stevens & Jennifer Roberts & John Brazier, 2005. "Health state values for the HUI 2 descriptive system: results from a UK survey," Health Economics, John Wiley & Sons, Ltd., vol. 14(3), pages 231-244.
  28. Chris McCabe & Simon Dixon, 2000. "Testing the Validity of Cost-Effectiveness Models," PharmacoEconomics, Springer Healthcare | Adis, vol. 17(5), pages 501-513.
  29. Chris J. McCabe & Ron L. Akehurst & Jeff Kirsch & Malcolm Whitfield & Martin Backhouse & Anthony D. Woolf & David L. Scott & Paul Emery & Ian Haslock, 1998. "Choice of NSAID and Management Strategy in Rheumatoid Arthritis and Osteoarthritis: The Impact on Costs and Outcomes in the UK," PharmacoEconomics, Springer Healthcare | Adis, vol. 14(2), pages 191-199.

NEP Fields

5 papers by this author were announced in NEP, and specifically in the following field reports (number of papers):
  1. NEP-HEA: Health Economics (4) 2013-11-02 2013-11-02 2013-11-02 2013-11-02. Author is listed
  2. NEP-UPT: Utility Models & Prospect Theory (2) 2013-11-02 2013-11-02. Author is listed

Statistics

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

Co-authorship network on CollEc

Corrections

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Christopher McCabe should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.